FindTrial
Sign In

Vancomycin (VAN) treatment

DRUG3 trials

Sponsors

University Hospital, Montpellier, Medical University of Warsaw, Atlantic Health System

Conditions

Clostridioides Difficile InfectionClostridioides Difficile Infection RecurrenceComparative Effectiveness of CDI TreatmentsFecal Microbiota Transplantation (FMT)FidaxomicinInfection Related to Vascular ProthesisInfection Related to Ventricular Assist DeviceInfective Endocarditis

Phase 3

Implementation of Vancomycin Powder Application in the Emergency Department for Open Fractures
Not yet recruitingNCT07659886
Atlantic Health SystemOpen Fracture
Start: 2026-06-10End: 2027-06-10Target: 100Updated: 2026-06-22

Unknown Phase

Retrospective Analysis of Nephrotoxicity During Daptomycin Versus Vancomycin Treatments in High Risk Patients
CompletedNCT03961503
University Hospital, MontpellierInfection Related to Vascular Prothesis, Infection Related to Ventricular Assist Device, Infective Endocarditis +2
Start: 2016-01-01End: 2016-01-30Updated: 2019-05-23
STOP-CDI: Efficacy of Fecal Microbiota Transplantation vs Fidaxomicin vs Vancomycin in Treating and Preventing Relapse of Clostridioides Difficile Infection
Not yet recruitingNCT07120490
Medical University of WarsawClostridioides Difficile Infection, Clostridioides Difficile Infection Recurrence, Comparative Effectiveness of CDI Treatments +3
Start: 2025-10-31End: 2027-04-30Target: 424Updated: 2025-08-13